retatrutide clinical trials safety data efficacy Retatrutide, an experimental weight-loss drug, has not been approved by retatrutide clinical trial results safety – Experimental drug retatrutide cut weight

No data, photos, claims or any other information is associated with results derived from clinical trials, studies or public information and is always representative of Rae Rx patient experience

BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice

Epub 2022 Jul 5

GLP-1s have transformed weight loss and diabetes

In the non-diabetes cohort, participants receiving the highest dose of retatrutide (12 mg weekly) achieved a mean body weight reduction of approximately 24% over 48 weeks a figure that substantially exceeds weight loss outcomes reported with currently approved agents at comparable timepoints

Cohen acknowledged he is "privileged to have access to a GLP-1" and that "everybody should through insurance." Mounjaro currently sells for $1,079.77 per prescription, according to the Lilly website, though the final retail price may vary depending on insurance coverage